| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.168 | 17.907 | 2.114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 26.168 | 18.582 | 2.115 | 688 | 598 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 22.610 | 27.262 | 9.409 | 1.135 | 1.258 | 22 | 20 | 20 | 20 | 15 |
| Gross Profit/Loss - EUR | 3.557 | -8.680 | -7.294 | -448 | -660 | -22 | -20 | -20 | -20 | -15 |
| Net Profit/Loss - EUR | 2.772 | -8.868 | -7.315 | -468 | -678 | -22 | -20 | -20 | -20 | -15 |
| Employees | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cris Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.052 | 2.148 | 1.069 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.153 | 1.966 | 755 | 1.559 | 153 | 126 | 124 | 106 | 106 | 105 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.057 | 1.622 | 379 | 1.189 | 146 | 124 | 121 | 104 | 103 | 103 |
| Cash | 1.096 | 344 | 376 | 370 | 7 | 2 | 2 | 2 | 2 | 2 |
| Shareholders Funds | 2.125 | -6.765 | -13.966 | -14.178 | -14.581 | -14.327 | -14.030 | -14.093 | -14.071 | -14.007 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.081 | 10.879 | 15.789 | 15.737 | 14.734 | 14.453 | 14.153 | 14.199 | 14.176 | 14.112 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7430 - 7430" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Cris Intermed Srl